文献速递妇科

美国妇科癌症患者死亡地点趋势

Trends in Place of Death Among Patients With Gynecologic Cancer in the United States.
PubMed 文献 · Obstet Gynecol · 2018-01-01

该研究利用2003至2015年美国死亡证明数据,回顾性分析妇科癌症(卵巢癌、子宫癌、宫颈癌、外阴癌)患者的死亡地点变化,并与乳腺癌、肺癌、结直肠癌比较。结果显示妇科癌症死于家中或临终关怀机构的比率从40.5%升至59.5%,相对增加47.2%,调整后每年增加1.6个百分点。

要点

  • 妇科癌症死于家中或临终关怀机构的比率从2003年40.5%升至2015年59.5%,相对增加47.2%。
  • 调整后妇科癌症该比率每年增加1.6个百分点(95%CI 1.5-1.6)。
  • 肺癌、乳腺癌、结直肠癌的每年增幅分别为1.5、1.4、1.5个百分点,与妇科癌症趋势存在差异。

核心结论

  • 2003至2015年间,妇科癌症死于家中或临终关怀机构的比率相对增加47.2%(40.5%至59.5%)。
  • 该趋势可能反映预立医疗照护计划及基于价值的治疗决策增加。

研究设计与样本

  • 回顾性横断面研究,使用美国死亡证明全国数据(Mortality Multiple Cause-of-Death Public Use Record Data)。
  • 纳入2003至2015年死于妇科、乳腺、肺癌及结直肠癌的所有女性,死因按ICD-10确定。
  • 采用普通最小二乘线性概率模型回归分析,控制年龄、种族、族裔、婚姻状况和教育程度。

主要发现

  • 2003至2015年共2,133,056名女性死于妇科、肺癌、乳腺癌及结直肠癌。
  • 其中359,340名死于妇科恶性肿瘤:卵巢癌188,366例(52.4%)、子宫癌106,454例(29.6%)、宫颈癌52,320例(14.6%)、外阴癌12,200例(3.4%)。
  • 总体49.2%(176,657例)的妇科癌症死亡发生在家中或临终关怀机构。
  • 妇科癌症死于家中或临终关怀机构的比率从2003年40.5%升至2015年59.5%,相对增加47.2%。
  • 调整分析中,妇科癌症该比率每年增加1.6个百分点(95%CI 1.5-1.6),肺癌为1.5(95%CI 1.4-1.5,P<.001)、乳腺癌为1.4(95%CI 1.4-1.5,P<.001)、结直肠癌为1.5(95%CI 1.4-1.5,P=.09)个百分点/年。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the change over time in place of death (hospital, home, hospice) among all women in the United States who died of gynecologic malignancies and compare them with other leading causes of female cancer deaths. METHODS: This is a retrospective cross-sectional study using national death certificate data from the Mortality Multiple Cause-of-Death Public Use Record Data. All women who died from gynecologic, breast, lung, and colorectal cancers were identified according to International Classification of Diseases, 10 Revision, cause of death from 2003 to 2015. Regression analyses with ordinary least-squares linear probability modeling were used to test for differences in location of death over time, and differences in trends by cancer type, while controlling for age, race, ethnicity, marital status, and education status. RESULTS: From 2003 to 2015, 2,133,056 women died from gynecologic, lung, breast, and colorectal malignancies in the United States. A total of 359,340 died from gynecologic malignancies, including ovarian cancer (n=188,366 [52.4%]), uterine cancer (n=106,454 [29.6%]), cervical cancer (n=52,320 [14.6%]), and vulvar cancer (n=12,200 [3.4%]). Overall, 49.2% (n=176,657) of gynecologic cancer deaths occurred at home or in hospice. The relative increase from 2003 to 2015 in the rate of deaths at home or in hospice was 47.2% for gynecologic cancer deaths (40.5% in 2003 to 59.5% in 2015). In adjusted analyses, the trend in the percentage of deaths at home or in hospice increased at a rate of 1.6 percentage points per year for gynecologic cancer deaths (95% CI 1.5-1.6) vs 1.5 (95% CI 1.4-1.5, P<.001), 1.4 (95% CI 1.4-1.5, P<.001), and 1.5 (95% CI 1.4-1.5, P=.09) percentage points per year for lung, breast, and colorectal cancer deaths, respectively. CONCLUSION: Between 2003 and 2015, there was a 47.2% increase (40.5-59.5%) in the rates of gynecologic cancer deaths occurring at home or in hospice. This trend may represent an increase in advance care planning and value-based treatment decisions.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hicks-Courant K, Melamed A, Worley MJ, et al. Trends in Place of Death Among Patients With Gynecologic Cancer in the United States. Obstet Gynecol. 2018. PMID: 29742673. doi:10.1097/AOG.0000000000002614

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。